Cameron Curley

Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial

Glen Kennedy, Antiopi Varelias, Slavica Vučković et al. · The Lancet Oncology · 2014 · 211 citations

Inflammation, Phase 1/2, Cell Therapy +13

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis

Glen Kennedy, Siok‐Keen Tey, Luke Buizen et al. · Blood · 2021 · 48 citations · Full text

Outcomes after major or bidirectional ABO‐mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor‐type secretor plasma with or without plasma exchange

Cameron Curley, Elango Pillai, Kari Mudie et al. · Transfusion · 2011 · 39 citations

Phase I Trial of Inducible Caspase 9 T Cells in Adult Stem Cell Transplant Demonstrates Massive Clonotypic Proliferative Potential and Long-term Persistence of Transgenic T Cells

Ping Zhang, Jyothy Raju, Md Ashik Ullah et al. · Clinical Cancer Research · 2019 · 26 citations · Full text

A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

Midori Nakagaki, Michael Barras, Cameron Curley et al. · Supportive Care in Cancer · 2016 · 22 citations

Chemotherapy-induced Nausea, Medicine, Psychotropic Medication +3